Sequent Scientific Ltd.

NSE: SEQUENT | BSE: 512529 | ISIN: INE807F01027 |Industry: Pharmaceuticals
|Expensive Star
151.10 -3.35 (-2.17%)
NSE Oct 26, 2020 12:49 PM
Volume: 495.5K

Sequent Scientific Ltd.    
09 Nov 2017

Demerger of the Human API Business into Solara Active Pharma Sciences Limited which will
also house the Commodity API Business of Strides Shasun Limited, will help achieve critical
scale & size and emerge as one of the largest API companies from India. This decision, to part
with the business from Sequent was taken considering the dynamic regulatory landscape in
API industry along with the growing opportunities for a pure-play API player from India. The
demerger awaits the final nod from the National Company Law Tribunal, Mumbai, and will
be value accretive for its shareholder.

Rudra Shares and Stock Brokers Ltd
Sequent Scientific Ltd. has gained 105.58% in the last 6 Months
More from Sequent Scientific Ltd.